Gyre Therapeutics, Inc. GYRE Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash

Effect of currency exchange rate changes on cash, cash equivalents, and restricted cash at other companies

GATXGATX

$1.75M+243%

CarGurus, Inc.CARG

-$613K-186%

Achieve Life SciencesACHV

$4K—

ADTRAN Holdings, Inc.ADTN

-$2.56M-2,024%

SPS CommerceSPSC

$288K-56.4%

SeaboardSEB

$0-100%

Other financials

Income statement

See full

Revenue$22.5M+2.1%

Gross profit$21.3M+0.6%

Operating income-$9.4M-512%

Net income-$8.7M-422%

EPS (diluted)-$0.10—

Balance sheet

See full

Cash & equivalents$37.5M+149%

Total debt$823.0K-48.1%

Total equity$101.3M+48.7%

Total assets$162.0M+24.8%

Cash flow

See full

Operating cash flow$3.2M+2,565%

CapEx$178.0K+45.9%

Free cash flow$3.0M+1,296%

Valuation

See full

Market cap$694.58M-4.7%

Enterprise value$657.9M-8.0%

P/S5.9×-1.3×

Profitability

See full

Gross margin95.1%-1.1pp

Operating margin-0.1%-10.4pp

Net margin6.3%+3.3pp

FCF margin2.6%—

Returns & leverage

See full

Return on equity8.2%+4.2pp

Debt / equity0×0.0×

Current ratio4.6×+1.0×

Where this comes from

Reported directly by Gyre Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations.

The official record: Gyre Therapeutics, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Gyre Therapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Gyre Therapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash?: Gyre Therapeutics, Inc. (GYRE) reported effect of currency exchange rate changes on cash, cash equivalents, and restricted cash of $285K in Q1 2026.
How has Gyre Therapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash changed year-over-year?: Gyre Therapeutics, Inc.'s effect of currency exchange rate changes on cash, cash equivalents, and restricted cash increased by 470.0% year-over-year, from $50K to $285K.